GPX1 and breast carcinoma: This finding is supported by a recent study conducted in Poland showing that carrying Leu variant was associated with a significant 40% decrease in the breast cancer risk, suggesting a protective effect of GPX1 Leu variant (Jaworska et al., 2013).